Middle East and North Africa Position Statement on HIV/AIDS to the UN General Assembly Special Session High-Level Meeting on AIDS 6 – 8 June 2016 We, the undersigned communities of the MENA region;
Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm
The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB
Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor
The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure
According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population,
